As of 2026-06-26, the Relative Valuation of Amneal Pharmaceuticals Inc (AMRX) is 6.89 USD. This relative valuation is based on P/E multiples. With the latest stock price at 17.32 USD, the upside of Amneal Pharmaceuticals Inc based on Relative Valuation is -60.2%.
The range of the Relative Valuation is 4.62 - 8.98 USD.
| Range | Selected | |
| Trailing P/E multiples | 12.1x - 13.9x | 13.6x |
| Forward P/E multiples | 17.2x - 19.7x | 18.8x |
| Fair Price | 4.62 - 8.98 | 6.89 |
| Upside | -73.3% - -48.2% | -60.2% |
| Date | P/E |
| 2026-06-25 | 45.25 |
| 2026-06-24 | 45.12 |
| 2026-06-23 | 43.52 |
| 2026-06-22 | 42.09 |
| 2026-06-18 | 42.35 |
| 2026-06-17 | 42.53 |
| 2026-06-16 | 42.45 |
| 2026-06-15 | 42.43 |
| 2026-06-12 | 42.32 |
| 2026-06-11 | 42.69 |
| 2026-06-10 | 40.02 |
| 2026-06-09 | 38.38 |
| 2026-06-08 | 35.82 |
| 2026-06-05 | 35.92 |
| 2026-06-04 | 35.32 |
| 2026-06-03 | 33.63 |
| 2026-06-02 | 33.05 |
| 2026-06-01 | 33.70 |
| 2026-05-29 | 34.41 |
| 2026-05-28 | 33.83 |
| 2026-05-27 | 33.39 |
| 2026-05-26 | 33.41 |
| 2026-05-22 | 32.45 |
| 2026-05-21 | 32.45 |
| 2026-05-20 | 31.95 |
| 2026-05-19 | 30.85 |
| 2026-05-18 | 31.14 |
| 2026-05-15 | 31.17 |
| 2026-05-14 | 31.95 |
| 2026-05-13 | 32.37 |
| 2026-05-12 | 32.92 |
| 2026-05-11 | 33.39 |
| 2026-05-08 | 34.48 |
| 2026-05-07 | 35.84 |
| 2026-05-06 | 35.58 |
| 2026-05-05 | 35.03 |
| 2026-05-04 | 34.25 |
| 2026-05-01 | 33.52 |
| 2026-04-30 | 33.62 |
| 2026-04-29 | 33.44 |
| 2026-04-28 | 33.27 |
| 2026-04-27 | 32.84 |
| 2026-04-24 | 32.71 |
| 2026-04-23 | 33.05 |
| 2026-04-22 | 33.49 |
| 2026-04-21 | 34.01 |
| 2026-04-20 | 34.64 |
| 2026-04-17 | 36.34 |
| 2026-04-16 | 34.20 |
| 2026-04-15 | 34.09 |